REBLOZYL® (luspatercept-aamt) logo
Now approved for earlier treatment of MDS-related anemia badge

INDICATIONS (1 of 3)

REBLOZYL® (luspatercept-aamt) is a prescription medicine used to treat anemia (low red blood cells) without previous erythropoiesis stimulating agent use (ESA-naïve) in adult patients with very low- to intermediate-risk myelodysplastic syndromes (MDS) who may require regular red blood cell (RBC) transfusions.

It is not known if REBLOZYL is safe or effective in children under 18 years of age.

This website is best viewed using the horizontal display on your tablet device.

This website is best viewed using the vertical display on your mobile device.

Hypothetical patient with anemia in beta thalassemia (BT) Hypothetical patient with anemia in beta thalassemia (BT)

Starting and staying with REBLOZYL

How can I get the most from treatment with REBLOZYL?

Your doctor prescribed REBLOZYL to treat the anemia associated with your transfusion-dependent beta (β) thalassemia (BT). This is an important part of managing your anemia associated with BT.

REBLOZYL can help manage anemia and may help reduce the number of red blood cell (RBC) transfusions you may need over time.

Before you start REBLOZYL treatment, it’s important to set treatment goals, including potential RBC transfusion reduction, with your healthcare team. Treatment goals can help you stay focused on what you want to achieve with REBLOZYL treatment. Be sure to keep talking with your healthcare team about what you want from treatment. Together, you can make sure you get the most out of REBLOZYL.

Getting the most from your treatment means working closely with your healthcare team to monitor:

  • New or changing symptoms
  • Your blood test results
  • The frequency of transfusions
  • The number of RBC units in each transfusion
  • Your REBLOZYL dose over time

It’s important that you keep track of all your transfusions and the number of RBC units in each transfusion while receiving REBLOZYL. This will help you talk with your healthcare team to get the most from REBLOZYL and meet your treatment goals. The BT Patient Brochure is a useful resource that can help you know what to expect throughout your REBLOZYL journey.

Hypothetical patient with anemia in beta thalassemia (BT) preparing for their doctor's appointment

How can I prepare for my appointments?

When you meet with your healthcare team to discuss how you’ve been feeling, it can be difficult to remember your symptoms since your last visit. It may help to keep track of any new or changing symptoms, including:

Hypothetical patient with anemia in beta thalassemia (BT) preparing for their doctor's appointment
  • How often or long you need to rest
  • Ability to do daily tasks and activities, such as driving
  • Feeling dizzy
  • Feeling out of breath
  • Feeling weak

It may be useful to write down how you feel in a notebook or on a tablet or smartphone. By keeping track of how you’re feeling over time, you and your healthcare team can see how REBLOZYL is working for you.

Talk with your healthcare team about how you’re doing.